Stay updated on MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6, indicating a frontend deployment; no substantive study details are reflected in the visible content.
    Difference
    0.1%
    Check dated 2026-08-29T18:55:57.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5, signaling a new edition of the page. This update appears to be a minor administrative change and does not alter the study details, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-08-08T22:57:48.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    A new Revision: v3.6.4 was added. The previous Revision: v3.6.3 was removed.
    Difference
    0.1%
    Check dated 2026-07-25T12:32:35.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page metadata was updated to Revision: v3.6.3, replacing the previous Revision: v3.6.2.
    Difference
    0.1%
    Check dated 2026-07-04T03:49:35.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.0 to v3.6.2, indicating a newer version of the study page is now in effect.
    Difference
    0.1%
    Check dated 2026-06-26T20:00:57.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Recruitment status now indicates the study is no longer enrolling participants. New user guidance pages and a refined Intervention/Treatment header were added to help users navigate and interpret the study details.
    Difference
    0.5%
    Check dated 2026-06-12T16:44:17.000Z thumbnail image

Stay in the know with updates to MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial page.